MLYS ▲ +1.8% - Mineralys Therapeutics, Inc.
$MLYS - Mineralys Therapeutics Presents New Lorundrostat Data in Participants with Hypertension and Chronic Kidney Disease at ASN Kidney Week 2026
22-OCT-2026 06:40 PM ET
Share this post
More filings for $MLYS
MLYS ▲ +3.1% - Mineralys Therapeutics, Inc.Oct 19, 2026MLYS ▼ -0.1% - Mineralys Therapeutics, Inc.Oct 9, 2026MLYS ▼ -0.4% - Mineralys Therapeutics, Inc.Oct 2, 2026MLYS ▼ -5.6% - Mineralys Therapeutics, Inc.Oct 1, 2026MLYS ▼ -4.5% - Mineralys Therapeutics, Inc.Sep 29, 2026MLYS ▼ -1.0% - Mineralys Therapeutics, Inc.Sep 24, 2026
View full $MLYS filing history →💬 Comments
Loading comments…
Leave a comment